Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.

Source:http://linkedlifedata.com/resource/pubmed/id/8262737

Download in:

View as

General Info

PMID
8262737